These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 2836742

  • 1. Pharmacokinetics of a spin-labeled rubomycin analog.
    Konovalova NP, Diatchkovskaya RF, Kukushkina GV, Volkova LM, Varfolomeev VN, Dombrovsky LS, Shapiro AB.
    Neoplasma; 1988; 35(2):185-90. PubMed ID: 2836742
    [Abstract] [Full Text] [Related]

  • 2. [Nitroxyl derivatives of rubomycin].
    Emanuél' NM, Konovalova NP, D'iachkovskaia RF, Denisova LK.
    Antibiotiki; 1982 Nov; 27(11):811-5. PubMed ID: 7181462
    [Abstract] [Full Text] [Related]

  • 3. [Effect of rubomycin and its paramagnetic analog on DNA synthesis].
    Dederer LIu, Gorbacheva LB.
    Antibiotiki; 1984 Jun; 29(6):442-5. PubMed ID: 6476807
    [Abstract] [Full Text] [Related]

  • 4. [Comparative study of the effect of daunorubicin and its nitroxyl derivative on in vitro function of rat liver mitochondria].
    Volk SE, Rogova OM.
    Antibiot Khimioter; 1991 Mar; 36(3):39-42. PubMed ID: 1877877
    [Abstract] [Full Text] [Related]

  • 5. Potential anticancer agents--nitroxyl derivatives of Rubomycin.
    Emanuel NM, Konovalova NP, Diatchkovskaya RF.
    Neoplasma; 1985 Mar; 32(3):285-92. PubMed ID: 4022191
    [Abstract] [Full Text] [Related]

  • 6. [Disorders in metabolism of superoxide radicals in tumor-bearing mice during development of Ehrlich ascites carcinoma and their normalization under the effect of ruboxyl].
    Gurevish SM, Vartanian LS, Nagler LG.
    Vopr Med Khim; 1993 Mar; 39(6):16-20. PubMed ID: 8303863
    [Abstract] [Full Text] [Related]

  • 7. [Synthesis of spin-labeled rubomycin and a study of its interaction with DNA].
    Povarov LS, Grigorian GL, Isaeva NN, Suskina VI.
    Antibiotiki; 1979 Jul; 24(7):488-93. PubMed ID: 223497
    [Abstract] [Full Text] [Related]

  • 8. [Characteristics of anthracycline-resistant strains of P388 leukemia].
    Goncharova SA, Demidova NS, Shiriaeva OA, Shevtsova VN, Konovalova NP.
    Eksp Onkol; 1987 Jul; 9(4):42-7. PubMed ID: 3678124
    [Abstract] [Full Text] [Related]

  • 9. [Effect of rubomycin (daunorubicin) and its nitroxyl analog on the functioning of rat heart mitochondria].
    Rogova OM, Volk SE.
    Antibiot Khimioter; 1991 May; 36(5):18-20. PubMed ID: 1953165
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of 4-[4"-(2",2",6",6"-tetramethyl-1"-piperidinyloxy) amino]-4'-demethylepipodophyllotoxin in mice bearing sarcoma 180.
    Jia ZP, Xie JW, Xie TQ.
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):197-200. PubMed ID: 7660809
    [Abstract] [Full Text] [Related]

  • 11. [Effect of Ruboxyl (nitroxyl derivative of daunorubicin) on hepatic metastases of colorectal carcinoma].
    Konovalova NP, Volkova LM, Codacci-Pisanelli D, Seminara P, Franchi F.
    Vopr Onkol; 2000 May; 46(4):438-41. PubMed ID: 11147420
    [Abstract] [Full Text] [Related]

  • 12. [Cytostatic action of semisynthetic rubomycin derivatives].
    Volkolupova OP, Makukho LV.
    Antibiotiki; 1982 Oct; 27(10):779-81. PubMed ID: 7149685
    [Abstract] [Full Text] [Related]

  • 13. [Cytostatic action of N-ethyl-13-dihydrorubomycin on the cells of various tumor strains].
    Volkolupova OP.
    Antibiotiki; 1984 Jun; 29(6):435-7. PubMed ID: 6548103
    [Abstract] [Full Text] [Related]

  • 14. A general survey of glutamine level in different tissues of murine solid tumor bearing mice before and after therapy with purified glutaminase.
    Maity P, Chakraborty S, Bhattacharya P.
    J Exp Clin Cancer Res; 2000 Jun; 19(2):161-4. PubMed ID: 10965812
    [Abstract] [Full Text] [Related]

  • 15. Correlations between cytotoxicity, biochemical effects, drug levels, and therapeutic effectiveness of daunomycin and adriamycin on Sarcoma 180 ascites in mice.
    Silvestrini R, Lenaz L, Di Fronzo G, Sanfilippo O.
    Cancer Res; 1973 Nov; 33(11):2954-8. PubMed ID: 4748447
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor activity of 4-demethoxydaunorubicin administered orally.
    Di Marco A, Casazza AM, Pratesi G.
    Cancer Treat Rep; 1977 Aug; 61(5):893-4. PubMed ID: 890695
    [No Abstract] [Full Text] [Related]

  • 17. [Biotransformation of sodium nitroprusside in tumor-bearing animals].
    Demidov MIa, Kleshchev AL, Sedov KR.
    Biull Eksp Biol Med; 1993 May; 115(5):512-3. PubMed ID: 8043838
    [Abstract] [Full Text] [Related]

  • 18. [Sensitivity of human tumor heterografts to a spin-labelled rubomycin derivative].
    Konovalova NP, D'iachkovskaia RF, Ganieva LKh, Volkova LM, Lapshin IM.
    Eksp Onkol; 1988 May; 10(4):54-9. PubMed ID: 3181076
    [Abstract] [Full Text] [Related]

  • 19. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J, Li C, Guo W, Li Y, Wang C, Zhang L, Zhang L, Hao Y, Wang Y.
    J Control Release; 2007 Apr 02; 118(2):204-15. PubMed ID: 17239468
    [Abstract] [Full Text] [Related]

  • 20. [Synthesis of rubomycin 13-tert-butoxycarbonylhydrazone and the study of its antitumor action].
    Povarov LS, Gol'dberg LE, Bazhanov VS, Olsuf'eva EN, Averbukh LA.
    Antibiotiki; 1981 Nov 02; 26(11):813-6. PubMed ID: 6895688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.